ArticleACS omega2025
Silk-Derived Peptide Modification to Polymers Improves the Miscibility of Composite Materials with Silk Fibroin.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silk fibroin (SF)/polymer composite materials typically exhibit degraded material strength because of their low miscibility. Therefore, we hypothesize that compatibility issues can be solved by modifying SF primary structure motif peptides into polymers. Physical property and structural analyses are performed on fabricated SF/polymer composites. These results suggest that miscibility is improved by modifying the peptide in terms of its thermal properties and molecular mobility. Further, physical properties are improved by peptide modification and are correlated with molecular structure. These findings indicate that SF primary structure motif peptide modification is an innovative technology that can solve the miscibility issue of SF/polymer composite materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.